DR. CHIDOZIE CHARLES AGU M.D.
Prescription History 1982952156
Internal Medicine in Albuquerque, NM
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. CHIDOZIE CHARLES AGU M.D., an active Internal Medicine specialist practicing in Albuquerque, NM. Our medical registry currently tracks 40 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 2,325 documented patient claims. Among these therapy options, the most frequently utilized medication is Albuterol Sulfate Hfa, which accounts for 307 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2024)Rx (2024) | Avg Cost per FillCost / Fill | Vs. Other NM PrescribersVs. NM Avg |
|---|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 307 | $27.34▼ below NM avg | ▲ More than typical |
About Albuterol Sulfate Hfa: Albuterol (also known as salbutamol) is used to prevent and treat wheezing and shortness of breath caused by breathing problems (such as asthma, chronic obstructive pulmonary disease). Show more ▾ It is also used to prevent asthma brought on by exercise. It is a quick-relief drug. Albuterol belongs to a class of drugs known as bronchodilators. It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. Controlling symptoms of breathing problems can decrease time lost from work or school. A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol. In 2024, this provider wrote 307 Medicare prescriptions for Albuterol Sulfate Hfa, about 5.5 times the volume of the typical New Mexico prescriber of this medication (55.5). Medicare paid an average of $27.34 per fill, versus $31.96 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NM prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NM average for this medication. 326.1 30-Day Fills standardized to 30-day supplies 7,814 Days of Medication total across all patients in 2024 | |||
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 293 | $808.21▼ below NM avg | ▲ More than typical |
About Trelegy Ellipta: This product is used to control and prevent symptoms (such as wheezing and shortness of breath) caused by asthma and ongoing lung disease (chronic obstructive pulmonary disease-COPD, which includes chronic bronchitis and emphysema). Show more ▾ Controlling symptoms of breathing problems helps you stay active. This inhaler contains 3 medications: fluticasone, umeclidinium, and vilanterol. Fluticasone belongs to a class of drugs known as corticosteroids. It works by reducing swelling of the airways in the lungs to make breathing easier. Umeclidinium belongs to a class of drugs known as anticholinergics and vilanterol is a LABA medication. Both drugs work by relaxing the muscles around the airways so that they open up and you can breathe more easily. Both drugs are also known as bronchodilators. When used alone, long-acting beta agonists (such as vilanterol) may rarely increase the risk of serious (sometimes fatal) asthma-related breathing problems. However, combination products containing both an inhaled corticosteroid and long-acting beta agonist, such as this product, do not increase the risk of serious asthma-related breathing problems. For asthma treatment, this product should be used when breathing problems are not well controlled with two asthma-control medications (such as inhaled corticosteroid and long-acting beta agonist) or if your symptoms need combination treatment. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden shortness of breath. If sudden breathing problems occur, use your quick-relief inhaler as prescribed. In 2024, this provider wrote 293 Medicare prescriptions for Trelegy Ellipta, about 7.1 times the volume of the typical New Mexico prescriber of this medication (41.5). Medicare paid an average of $808.21 per fill, versus $834.70 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NM prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NM average for this medication. 373 30-Day Fills standardized to 30-day supplies 11,190 Days of Medication total across all patients in 2024 | |||
| Prednisone | 205 | $7.63 | ▲ More than typical |
About Prednisone: Prednisone is used to treat conditions such as arthritis, blood disorders, breathing problems, severe allergies, skin diseases, cancer, eye problems, and immune system disorders. Show more ▾ Prednisone belongs to a class of drugs known as corticosteroids. It decreases your immune system's response to various diseases to reduce symptoms such as swelling and allergic-type reactions. A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver. In 2024, this provider wrote 205 Medicare prescriptions for Prednisone, about 5.2 times the volume of the typical New Mexico prescriber of this medication (39.2). Medicare paid an average of $7.63 per fill, versus $4.78 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NM prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 249.4 30-Day Fills standardized to 30-day supplies 5,311 Days of Medication total across all patients in 2024 | |||
| Spiriva RespimatTiotropium Bromide | 150 | $582.99▼ below NM avg | ▲ More than typical |
About Spiriva Respimat: Tiotropium is used to treat lung diseases such as asthma and COPD (bronchitis, emphysema). Show more ▾ It must be used regularly to prevent wheezing and shortness of breath. It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. Tiotropium belongs to a class of drugs known as anticholinergics. Controlling symptoms of breathing problems can decrease time lost from work or school. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden breathing problems. If wheezing or sudden shortness of breath occurs, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed. A scopolamine derivative and CHOLINERGIC ANTAGONIST that functions as a BRONCHODILATOR AGENT. It is used in the treatment of CHRONIC OBSTRUCTIVE PULMONARY DISEASE. In 2024, this provider wrote 150 Medicare prescriptions for Spiriva Respimat, about 4.6 times the volume of the typical New Mexico prescriber of this medication (32.3). Medicare paid an average of $582.99 per fill, versus $675.37 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NM prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NM average for this medication. 177 30-Day Fills standardized to 30-day supplies 5,310 Days of Medication total across all patients in 2024 | |||
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 149 | $580.91▼ below NM avg | ▲ More than typical |
About Stiolto Respimat: This product is used to control and prevent symptoms (such as wheezing and shortness of breath) caused by ongoing lung disease (chronic obstructive pulmonary disease-COPD, which includes chronic bronchitis and emphysema). Show more ▾ Controlling symptoms of breathing problems helps you stay active. This inhaler contains 2 medications: tiotropium and olodaterol. Both drugs work by relaxing the muscles around the airways so that they open up and you can breathe more easily. Tiotropium belongs to a class of drugs known as anticholinergics. Olodaterol belongs to the class of drugs known as long-acting inhaled beta-agonists (LABAs). Both drugs are also known as bronchodilators. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden shortness of breath. If sudden breathing problems occur, use your quick-relief inhaler as prescribed. Tiotropium/olodaterol is not approved to treat asthma. People with asthma using long-acting inhaled beta agonists (such as olodaterol) without also using an inhaled corticosteroid may have an increased risk of serious (sometimes fatal) breathing problems. In 2024, this provider wrote 149 Medicare prescriptions for Stiolto Respimat, about 4.1 times the volume of the typical New Mexico prescriber of this medication (36). Medicare paid an average of $580.91 per fill, versus $657.22 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NM prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NM average for this medication. 187 30-Day Fills standardized to 30-day supplies 5,610 Days of Medication total across all patients in 2024 | |||
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 131 | $649.21 | ▲ More than typical |
About Anoro Ellipta: This product is used to control and prevent symptoms (such as wheezing and shortness of breath) caused by ongoing lung disease (chronic obstructive pulmonary disease-COPD, which includes chronic bronchitis and emphysema). Show more ▾ Controlling symptoms of breathing problems helps you stay active. This inhaler contains 2 medications: umeclidinium and vilanterol. Both drugs work by relaxing the muscles around the airways so that they open up and you can breathe more easily. Umeclidinium belongs to a class of drugs known as anticholinergics. Vilanterol belongs to the class of drugs known as long-acting beta agonists (LABAs). Both drugs are also known as bronchodilators. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden shortness of breath. If sudden breathing problems occur, use your quick-relief inhaler as prescribed. Umeclidinium/vilanterol is not approved to treat asthma. People with asthma using long-acting inhaled beta agonists (such as vilanterol) without also using an inhaled corticosteroid may have an increased risk of serious (sometimes fatal) breathing problems. In 2024, this provider wrote 131 Medicare prescriptions for Anoro Ellipta, about 4.3 times the volume of the typical New Mexico prescriber of this medication (30.6). Medicare paid an average of $649.21 per fill, versus $560.86 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NM prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 184 30-Day Fills standardized to 30-day supplies 5,520 Days of Medication total across all patients in 2024 | |||
| Montelukast Sodium | 121 | $12.48▼ below NM avg | ▲ More than typical |
About Montelukast Sodium: Montelukast is used to control and prevent symptoms caused by asthma (such as wheezing and shortness of breath). Show more ▾ It is also used before exercise to prevent breathing problems during exercise (bronchospasm). This medication can help decrease the number of times you need to use your quick relief inhaler. Montelukast is also used to relieve symptoms of hay fever and allergic rhinitis (such as sneezing, stuffy/runny/itchy nose). Since there are other allergy medications that may be safer (see also Warning section), this medication should be used for this condition only when you cannot take other allergy medications or they do not work well. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden asthma attacks or breathing problems. If an asthma attack or sudden shortness of breath occurs, use your quick-relief inhaler as prescribed. This drug works by blocking certain natural substances (leukotrienes) that may cause or worsen asthma and allergies. It helps make breathing easier by reducing swelling (inflammation) in the airways. A leukotriene D4 receptor antagonist. In 2024, this provider wrote 121 Medicare prescriptions for Montelukast Sodium, about 2.4 times the volume of the typical New Mexico prescriber of this medication (50.5). Medicare paid an average of $12.48 per fill, versus $12.64 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NM prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NM average for this medication. 278.2 30-Day Fills standardized to 30-day supplies 8,302 Days of Medication total across all patients in 2024 | |||
| SymbicortBudesonide/Formoterol Fumarate | 119 | $320.32▼ below NM avg | ▲ More than typical |
About Symbicort: This product is used to control and prevent symptoms (wheezing and shortness of breath) caused by asthma or ongoing lung disease (chronic obstructive pulmonary disease-COPD, which includes chronic bronchitis and emphysema). Show more ▾ It contains 2 medications: budesonide and formoterol. Budesonide belongs to a class of drugs known as corticosteroids. It works by reducing the irritation and swelling of the airways. Formoterol belongs to the class of drugs known as long-acting beta agonists. It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. Controlling symptoms of breathing problems can decrease time lost from work or school. When used alone, long-acting beta agonists (such as formoterol) may rarely increase the risk of serious (sometimes fatal) asthma-related breathing problems. However, combination inhaled corticosteroid and long-acting beta agonists, such as this product, do not increase the risk of serious asthma-related breathing problems. Before using this medication, it is important to learn how to use it properly. If an asthma attack occurs, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed. See also How to Use section. A pharmaceutical preparation of budesonide and formoterol fumarate that is used as an ANTI-ASTHMATIC AGENT and for the treatment of CHRONIC OBSTRUCTIVE PULMONARY DISEASE. In 2024, this provider wrote 119 Medicare prescriptions for Symbicort, about 4.1 times the volume of the typical New Mexico prescriber of this medication (29). Medicare paid an average of $320.32 per fill, versus $321.48 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NM prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NM average for this medication. 170 30-Day Fills standardized to 30-day supplies 5,072 Days of Medication total across all patients in 2024 | |||
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 73 | $139.36▼ below NM avg | ▲ More than typical |
About Fluticasone-Salmeterol: This product is used to control and prevent symptoms (wheezing and shortness of breath) caused by asthma or ongoing lung disease (chronic obstructive pulmonary disease-COPD, which includes chronic bronchitis and emphysema). Show more ▾ It contains 2 medications: fluticasone and salmeterol. Fluticasone belongs to a class of drugs known as corticosteroids. It works by reducing the irritation and swelling of the airways. Salmeterol belongs to the class of drugs known as long-acting beta agonists. It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. Controlling symptoms of breathing problems can decrease time lost from work or school. When used alone, long-acting beta agonists (such as salmeterol) may rarely increase the risk of serious (sometimes fatal) asthma-related breathing problems. However, combination inhaled corticosteroid and long-acting beta agonists, such as this product, do not increase the risk of serious asthma-related breathing problems. For asthma treatment, this product should be used when breathing problems are not well controlled with one asthma-control medication (such as inhaled corticosteroid) or if your symptoms need combination treatment. Before using this medication, it is important to learn how to use it properly. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden asthma attacks. If an asthma attack occurs, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed. A drug combination of fluticasone and salmeterol that is used as an inhaler formulation to manage the symptoms of ASTHMA and CHRONIC OBSTRUCTIVE PULMONARY DISEASE. In 2024, this provider wrote 73 Medicare prescriptions for Fluticasone-Salmeterol, about 3 times the volume of the typical New Mexico prescriber of this medication (24.5). Medicare paid an average of $139.36 per fill, versus $165.38 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NM prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NM average for this medication. 123 30-Day Fills standardized to 30-day supplies 3,690 Days of Medication total across all patients in 2024 | |||
| Breo ElliptaFluticasone/Vilanterol | 58 | $449.51▼ below NM avg | ▲ More than typical |
About Breo Ellipta: This medication is used to prevent and decrease symptoms (wheezing and trouble breathing) caused by asthma and ongoing lung disease (chronic obstructive pulmonary disease-COPD, including chronic bronchitis and emphysema). Show more ▾ This inhaler contains 2 medications: fluticasone and vilanterol. Fluticasone belongs to a class of drugs known as corticosteroids. It works by reducing the swelling of the airways in the lungs to make breathing easier. Vilanterol belongs to a class of drugs known as long-acting beta agonists. It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. When used alone, long-acting beta agonists (like vilanterol) may rarely increase the risk of serious (sometimes fatal) asthma-related breathing problems. However, combination inhaled corticosteroid and long-acting beta agonists, such as this product, do not increase the risk of serious asthma-related breathing problems. For asthma treatment, this product should be used when breathing problems are not well controlled with one asthma-control medication (such as inhaled corticosteroid) or if your symptoms need combination treatment. Before using this medication, it is important to learn how to use it properly. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden asthma attacks. If an asthma attack occurs, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed. In 2024, this provider wrote 58 Medicare prescriptions for Breo Ellipta, about 2.3 times the volume of the typical New Mexico prescriber of this medication (25.4). Medicare paid an average of $449.51 per fill, versus $508.56 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NM prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NM average for this medication. 68 30-Day Fills standardized to 30-day supplies 2,040 Days of Medication total across all patients in 2024 | |||
| Ventolin HfaAlbuterol Sulfate | 57 | $65.69▼ below NM avg | ▲ More than typical |
About Ventolin Hfa: Albuterol (also known as salbutamol) is used to prevent and treat wheezing and shortness of breath caused by breathing problems (such as asthma, chronic obstructive pulmonary disease). Show more ▾ It is also used to prevent asthma brought on by exercise. It is a quick-relief drug. Albuterol belongs to a class of drugs known as bronchodilators. It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. Controlling symptoms of breathing problems can decrease time lost from work or school. A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol. In 2024, this provider wrote 57 Medicare prescriptions for Ventolin Hfa, about 2.4 times the volume of the typical New Mexico prescriber of this medication (24). Medicare paid an average of $65.69 per fill, versus $70.32 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NM prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NM average for this medication. 61.2 30-Day Fills standardized to 30-day supplies 1,334 Days of Medication total across all patients in 2024 | |||
| Fluticasone Propionate HfaFluticasone Propionate | 50 | $209.29▼ below NM avg | ▲ More than typical |
About Fluticasone Propionate Hfa: Fluticasone is used to control and prevent symptoms (such as wheezing and shortness of breath) caused by asthma. Show more ▾ It works by reducing swelling (inflammation) of the airways in the lungs to make breathing easier. Controlling symptoms of asthma helps you maintain your normal activities and decreases time lost from work or school. Fluticasone belongs to a class of drugs known as corticosteroids. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden asthma attacks. If an asthma attack occurs, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed. A STEROID with GLUCOCORTICOID RECEPTOR activity that is used to manage the symptoms of ASTHMA; ALLERGIC RHINITIS, and ATOPIC DERMATITIS. In 2024, this provider wrote 50 Medicare prescriptions for Fluticasone Propionate Hfa, about 2.7 times the volume of the typical New Mexico prescriber of this medication (18.5). Medicare paid an average of $209.29 per fill, versus $250.26 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NM prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NM average for this medication. 74 30-Day Fills standardized to 30-day supplies 2,220 Days of Medication total across all patients in 2024 | |||
| Arnuity ElliptaFluticasone Furoate | 43 | $301.21 | ▲ More than typical |
About Arnuity Ellipta: Fluticasone is used to control and prevent symptoms (such as wheezing and shortness of breath) caused by asthma. Show more ▾ Controlling symptoms of asthma helps you maintain your normal activities and decreases time lost from work or school. Fluticasone belongs to a class of drugs known as corticosteroids. It works by reducing swelling (inflammation) of the airways in the lungs to make breathing easier. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden asthma attacks. If an asthma attack occurs, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed. A STEROID with GLUCOCORTICOID RECEPTOR activity that is used to manage the symptoms of ASTHMA; ALLERGIC RHINITIS, and ATOPIC DERMATITIS. In 2024, this provider wrote 43 Medicare prescriptions for Arnuity Ellipta, about 1.7 times the volume of the typical New Mexico prescriber of this medication (24.8). Medicare paid an average of $301.21 per fill, versus $287.75 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NM prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 59 30-Day Fills standardized to 30-day supplies 1,770 Days of Medication total across all patients in 2024 | |||
| Fluticasone Propionate | 40 | $39.29 | ≈ Typical |
About Fluticasone Propionate: Fluticasone is used to relieve seasonal and year-round allergic and non-allergic nasal symptoms, such as stuffy/runny nose, itching, and sneezing. Show more ▾ It can also help relieve allergy eye symptoms such as itchy, watery eyes. This medication belongs to a class of drugs known as corticosteroids. It works in your nose to block the effects of substances that cause allergies (such as pollen, pet dander, dust mites, mold) and to reduce swelling. A STEROID with GLUCOCORTICOID RECEPTOR activity that is used to manage the symptoms of ASTHMA; ALLERGIC RHINITIS, and ATOPIC DERMATITIS. In 2024, this provider wrote 40 Medicare prescriptions for Fluticasone Propionate, about 88% of the volume of the typical New Mexico prescriber of this medication (45.5). Medicare paid an average of $39.29 per fill, versus $18.05 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NM prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 63 30-Day Fills standardized to 30-day supplies 1,815 Days of Medication total across all patients in 2024 | |||
| Azithromycin | 38 | $13.94 | ≈ Typical |
About Azithromycin: Azithromycin is used to treat a wide variety of bacterial infections. Show more ▾ It is a macrolide-type antibiotic. It works by stopping the growth of bacteria. This medication will not work for viral infections (such as common cold, flu). Unnecessary use or misuse of any antibiotic can lead to its decreased effectiveness. A semi-synthetic macrolide antibiotic structurally related to ERYTHROMYCIN. It has been used in the treatment of Mycobacterium avium intracellulare infections, toxoplasmosis, and cryptosporidiosis. In 2024, this provider wrote 38 Medicare prescriptions for Azithromycin, about 1.2 times the volume of the typical New Mexico prescriber of this medication (31.4). Medicare paid an average of $13.94 per fill, versus $6.11 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NM prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 43 30-Day Fills standardized to 30-day supplies 555 Days of Medication total across all patients in 2024 | |||
| Qvar RedihalerBeclomethasone Dipropionate | 36 | $280.82▼ below NM avg | ▲ More than typical |
About Qvar Redihaler: Beclomethasone is used to prevent and control symptoms (wheezing and shortness of breath) caused by asthma. Show more ▾ This medication belongs to a class of drugs known as corticosteroids. It works by reducing the swelling of the airways in the lungs to make breathing easier. This medication must be used regularly to prevent breathing problems (attacks of wheezing/shortness of breath). It does not work right away and should not be used to relieve an asthma attack. If an attack occurs, use your quick-relief inhaler as prescribed. An anti-inflammatory, synthetic glucocorticoid. It is used topically as an anti-inflammatory agent and in aerosol form for the treatment of ASTHMA. In 2024, this provider wrote 36 Medicare prescriptions for Qvar Redihaler, about 2 times the volume of the typical New Mexico prescriber of this medication (18.1). Medicare paid an average of $280.82 per fill, versus $312.47 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NM prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NM average for this medication. 39 30-Day Fills standardized to 30-day supplies 1,170 Days of Medication total across all patients in 2024 | |||
| Wixela InhubFluticasone Propion/Salmeterol | 36 | $117.04▼ below NM avg | ▲ More than typical |
About Wixela Inhub: This product is used to control and prevent symptoms (wheezing and shortness of breath) caused by asthma or ongoing lung disease (chronic obstructive pulmonary disease-COPD, which includes chronic bronchitis and emphysema). Show more ▾ It contains 2 medications: fluticasone and salmeterol. Fluticasone belongs to a class of drugs known as corticosteroids. It works by reducing the irritation and swelling of the airways. Salmeterol belongs to the class of drugs known as long-acting beta agonists. It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. Controlling symptoms of breathing problems can decrease time lost from work or school. When used alone, long-acting beta agonists (such as salmeterol) may rarely increase the risk of serious (sometimes fatal) asthma-related breathing problems. However, combination inhaled corticosteroid and long-acting beta agonists, such as this product, do not increase the risk of serious asthma-related breathing problems. For asthma treatment, this product should be used when breathing problems are not well controlled with one asthma-control medication (such as inhaled corticosteroid) or if your symptoms need combination treatment. Before using this medication, it is important to learn how to use it properly. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden asthma attacks. If an asthma attack occurs, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed. In 2024, this provider wrote 36 Medicare prescriptions for Wixela Inhub, about 1.7 times the volume of the typical New Mexico prescriber of this medication (21.1). Medicare paid an average of $117.04 per fill, versus $148.21 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NM prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NM average for this medication. 52 30-Day Fills standardized to 30-day supplies 1,560 Days of Medication total across all patients in 2024 | |||
| Advair HfaFluticasone Propion/Salmeterol | 35 | $595.25 | ▲ More than typical |
About Advair Hfa: This product is used to control and prevent symptoms (wheezing and shortness of breath) caused by asthma. Show more ▾ It contains 2 medications: fluticasone and salmeterol. Fluticasone belongs to a class of drugs known as corticosteroids. It works by reducing the irritation and swelling of the airways. Salmeterol belongs to the class of drugs known as long-acting beta agonists. It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. Controlling symptoms of breathing problems can decrease time lost from work or school. When used alone, long-acting beta agonists (such as salmeterol) may rarely increase the risk of serious (sometimes fatal) asthma-related breathing problems. However, combination inhaled corticosteroid and long-acting beta agonists, such as this product, do not increase the risk of serious asthma-related breathing problems. This product should be used when breathing problems are not well controlled with one asthma-control medication (such as inhaled corticosteroid) or if your asthma symptoms need combination treatment. Before using this medication, it is important to learn how to use it properly. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden asthma attacks. If an asthma attack occurs, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed. A drug combination of fluticasone and salmeterol that is used as an inhaler formulation to manage the symptoms of ASTHMA and CHRONIC OBSTRUCTIVE PULMONARY DISEASE. In 2024, this provider wrote 35 Medicare prescriptions for Advair Hfa, about 1.8 times the volume of the typical New Mexico prescriber of this medication (19.1). Medicare paid an average of $595.25 per fill, versus $425.37 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NM prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 57 30-Day Fills standardized to 30-day supplies 1,710 Days of Medication total across all patients in 2024 | |||
| Roflumilast | 34 | $22.28▼ below NM avg | ▲ More than typical |
About Roflumilast: Roflumilast is used to control and prevent symptoms (wheezing and shortness of breath) caused by ongoing lung disease (chronic obstructive pulmonary disease-COPD which includes bronchitis). Show more ▾ It should be used along with other medications (bronchodilators such as salmeterol, ipratropium) to treat COPD. It works by reducing the irritation and swelling of the airways. Controlling symptoms of breathing problems can decrease time lost from work or school. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden shortness of breath or wheezing. If sudden breathing problems occur, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed. In 2024, this provider wrote 34 Medicare prescriptions for Roflumilast, about 1.3 times the volume of the typical New Mexico prescriber of this medication (25.5). Medicare paid an average of $22.28 per fill, versus $83.08 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NM prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NM average for this medication. 53.6 30-Day Fills standardized to 30-day supplies 1,608 Days of Medication total across all patients in 2024 | |||
| MethotrexateMethotrexate Sodium | 29 | $19.34▼ below NM avg | ▼ Less than typical |
About Methotrexate: Methotrexate is used to treat certain types of cancer (such as acute lymphoblastic leukemia, non-Hodgkin's lymphoma), severe psoriasis that has not responded to other treatments, or rheumatoid arthritis. Show more ▾ It may also be used to treat a certain type of arthritis in children (polyarticular juvenile idiopathic arthritis - pJIA). Methotrexate belongs to a class of drugs known as antimetabolites. It works by slowing or stopping the growth of cancer cells and blocking the immune system from attacking healthy tissue. Early treatment of rheumatoid arthritis with methotrexate helps to reduce further joint damage and to preserve joint function. An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA. In 2024, this provider wrote 29 Medicare prescriptions for Methotrexate, about a third of the volume of the typical New Mexico prescriber of this medication (93.9). Medicare paid an average of $19.34 per fill, versus $24.26 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NM prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NM average for this medication. 36.4 30-Day Fills standardized to 30-day supplies 1,025 Days of Medication total across all patients in 2024 | |||
| Famotidine | 28 | $10.24▼ below NM avg | ▼ Less than typical |
About Famotidine: Famotidine is used to treat ulcers of the stomach and intestines and to prevent intestinal ulcers from coming back after they have healed. Show more ▾ This medication is also used to treat certain stomach and throat (esophagus) problems (such as erosive esophagitis, gastroesophageal reflux disease-GERD, Zollinger-Ellison syndrome). It works by decreasing the amount of acid your stomach makes. It relieves symptoms such as cough that doesn't go away, stomach pain, heartburn, and difficulty swallowing. Famotidine belongs to a class of drugs known as H2 blockers. This medication is also available without a prescription. It is used to prevent and treat heartburn and other symptoms caused by too much acid in the stomach (acid indigestion). If you are taking this medication for self-treatment, it is important to read the manufacturer's package instructions carefully so you know when to consult your doctor or pharmacist. A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion. In 2024, this provider wrote 28 Medicare prescriptions for Famotidine, about half the volume of the typical New Mexico prescriber of this medication (48). Medicare paid an average of $10.24 per fill, versus $16.19 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NM prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NM average for this medication. 36 30-Day Fills standardized to 30-day supplies 1,065 Days of Medication total across all patients in 2024 | |||
| Omeprazole | 27 | $10.70▼ below NM avg | ▼ Less than typical |
About Omeprazole: Omeprazole is used to treat certain stomach and esophagus problems (such as acid reflux, ulcers). Show more ▾ It works by decreasing the amount of acid your stomach makes. It relieves symptoms such as heartburn, difficulty swallowing, and cough. This medication helps heal acid damage to the stomach and esophagus, helps prevent ulcers, and may help prevent cancer of the esophagus. Omeprazole belongs to a class of drugs known as proton pump inhibitors (PPIs). If you are self-treating with this medication, over-the-counter omeprazole products are used to treat frequent heartburn (occurring 2 or more days a week). Since it may take 1 to 4 days to have full effect, these products do not relieve heartburn right away. For over-the-counter products, carefully read the package instructions to make sure the product is right for you. Check the ingredients on the label even if you have used the product before. The manufacturer may have changed the ingredients. Also, products with similar brand names may contain different ingredients meant for different purposes. Taking the wrong product could harm you. A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. In 2024, this provider wrote 27 Medicare prescriptions for Omeprazole, about a third of the volume of the typical New Mexico prescriber of this medication (74.6). Medicare paid an average of $10.70 per fill, versus $14.62 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NM prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NM average for this medication. 38 30-Day Fills standardized to 30-day supplies 1,140 Days of Medication total across all patients in 2024 | |||
| Bevespi AerosphereGlycopyrrolate/Formoterol Fum | 22 | $446.69▼ below NM avg | ▲ More than typical |
About Bevespi Aerosphere: This product is used to control and prevent symptoms (such as wheezing and shortness of breath) caused by ongoing lung disease (chronic obstructive pulmonary disease-COPD, which includes chronic bronchitis and emphysema). Show more ▾ Controlling symptoms of breathing problems helps you maintain your normal activities and decreases time lost from work or school. This inhaler contains 2 medications: glycopyrrolate and formoterol. Both drugs work by relaxing the muscles around the airways so that they open up and you can breathe more easily. Glycopyrrolate belongs to a class of drugs known as anticholinergics. Formoterol belongs to the class of drugs known as long-acting beta agonists (LABAs). Both drugs are also known as bronchodilators. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden breathing problems. If sudden shortness of breath occurs, use your quick-relief inhaler as prescribed. Glycopyrrolate/formoterol is not approved to treat asthma. People with asthma using long-acting inhaled beta agonists (such as formoterol) without also using an inhaled corticosteroid may have an increased risk of serious (sometimes fatal) breathing problems. In 2024, this provider wrote 22 Medicare prescriptions for Bevespi Aerosphere, about 1.4 times the volume of the typical New Mexico prescriber of this medication (15.2). Medicare paid an average of $446.69 per fill, versus $499.19 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NM prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NM average for this medication. 24 30-Day Fills standardized to 30-day supplies 720 Days of Medication total across all patients in 2024 | |||
| Spiriva HandihalerTiotropium Bromide | 21 | $499.96▼ below NM avg | ≈ Typical |
About Spiriva Handihaler: Tiotropium is used to control and prevent symptoms (such as wheezing, shortness of breath) caused by ongoing lung disease (chronic obstructive pulmonary disease-COPD which includes bronchitis and emphysema). Show more ▾ It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. Tiotropium belongs to a class of drugs known as anticholinergics. Controlling symptoms of breathing problems can decrease time lost from work or school. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden breathing problems. If wheezing or sudden shortness of breath occurs, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed. A scopolamine derivative and CHOLINERGIC ANTAGONIST that functions as a BRONCHODILATOR AGENT. It is used in the treatment of CHRONIC OBSTRUCTIVE PULMONARY DISEASE. In 2024, this provider wrote 21 Medicare prescriptions for Spiriva Handihaler, about 1.2 times the volume of the typical New Mexico prescriber of this medication (18.1). Medicare paid an average of $499.96 per fill, versus $702.68 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NM prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NM average for this medication. 21 30-Day Fills standardized to 30-day supplies 630 Days of Medication total across all patients in 2024 | |||
| Azathioprine | 20 | $24.63▼ below NM avg | ≈ Typical |
About Azathioprine: Azathioprine is used to prevent organ rejection in people who have received a kidney transplant. Show more ▾ It is usually taken along with other medications to allow your new kidney to function normally. Azathioprine is also used to treat rheumatoid arthritis. In this condition, the body's defense system (immune system) attacks healthy joints. Azathioprine belongs to a class of drugs known as immunosuppressants. It works by weakening the immune system to help your body accept the new kidney as if it were your own (in the case of an organ transplant) or to prevent further damage to your joints (in the case of rheumatoid arthritis). Talk to your doctor about the risks and benefits of azathioprine, especially when used by children and young adults. An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed) In 2024, this provider wrote 20 Medicare prescriptions for Azathioprine, about 85% of the volume of the typical New Mexico prescriber of this medication (23.5). Medicare paid an average of $24.63 per fill, versus $45.76 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NM prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NM average for this medication. 34 30-Day Fills standardized to 30-day supplies 1,020 Days of Medication total across all patients in 2024 | |||
| Combivent RespimatIpratropium/Albuterol Sulfate | 20 | $686.00 | ≈ Typical |
About Combivent Respimat: This product is used to treat and prevent symptoms (wheezing and shortness of breath) caused by ongoing lung disease (chronic obstructive pulmonary disease-COPD, which includes bronchitis and emphysema). Show more ▾ This product contains 2 medications: ipratropium and albuterol (also known as salbutamol). Both drugs work by relaxing the muscles around the airways so that the airways open up and you can breathe more easily. Controlling symptoms of breathing problems can decrease time lost from work or school. A combined pharmaceutical preparation of Ipratropium Bromide and Albuterol Sulfate that is used to treat the symptoms of ASTHMA and CHRONIC OBSTRUCTIVE PULMONARY DISEASE. In 2024, this provider wrote 20 Medicare prescriptions for Combivent Respimat, about the same volume as the typical New Mexico prescriber of this medication (18.9). Medicare paid an average of $686.00 per fill, versus $630.72 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NM prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 20 30-Day Fills standardized to 30-day supplies 495 Days of Medication total across all patients in 2024 | |||
| Azelastine Hcl | 20 | $18.33▼ below NM avg | ▼ Less than typical |
About Azelastine Hcl: This medication is used to relieve nasal symptoms such as runny/itching/stuffy nose, sneezing, and post-nasal drip caused by allergies or other conditions. Show more ▾ Azelastine belongs to a class of drugs known as antihistamines. It works by blocking certain natural substances called histamines that are responsible for nasal symptoms. Azeptin is azelastine hydrochloride; structure; eye drop formulation effective in relieving symptoms of allergic conjunctivitis; do not confuse with 5-loxin which is an extract of Boswellia. In 2024, this provider wrote 20 Medicare prescriptions for Azelastine Hcl, about half the volume of the typical New Mexico prescriber of this medication (35). Medicare paid an average of $18.33 per fill, versus $27.09 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NM prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NM average for this medication. 34.3 30-Day Fills standardized to 30-day supplies 1,020 Days of Medication total across all patients in 2024 | |||
| Amlodipine Besylate | 16 | $10.32 | ▼ Less than typical |
About Amlodipine Besylate: Amlodipine is used with or without other medications to treat high blood pressure. Show more ▾ Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. Amlodipine belongs to a class of drugs known as calcium channel blockers. It works by relaxing blood vessels so blood can flow more easily. Amlodipine is also used to prevent certain types of chest pain (angina). It may help to increase your ability to exercise and decrease the frequency of angina attacks. It should not be used to treat attacks of chest pain when they occur. Use other medications (such as sublingual nitroglycerin) to relieve attacks of chest pain as directed by your doctor. A long-acting dihydropyridine calcium channel blocker. It is effective in the treatment of ANGINA PECTORIS and HYPERTENSION. In 2024, this provider wrote 16 Medicare prescriptions for Amlodipine Besylate, about 16% of the volume of the typical New Mexico prescriber of this medication (100.8). Medicare paid an average of $10.32 per fill, versus $8.25 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NM prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 18 30-Day Fills standardized to 30-day supplies 540 Days of Medication total across all patients in 2024 | |||
| NucalaMepolizumab | 14 | $4,287.98▼ below NM avg | ▼ Less than typical |
About Nucala: This medication is used along with other medications to control and prevent symptoms (such as wheezing and shortness of breath) caused by asthma. Show more ▾ Controlling symptoms of asthma helps you do your normal activities and decreases time lost from work or school. Mepolizumab is also used to treat certain other immune system disorders (chronic rhinosinusitis with nasal polyps, eosinophilic granulomatosis with polyangiitis, hypereosinophilic syndrome). This medication works by decreasing a certain type of white blood cell (eosinophils). This effect helps reduce swelling (inflammation) of the airways to make breathing easier. It may also help reduce the size of nasal polyps, and lessen symptoms such as runny/stuffy nose, mucus in the throat, loss of smell, facial pain, and tiredness. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden asthma attacks or breathing problems. If an asthma attack occurs, use your quick-relief inhaler as prescribed. A humanized monoclonal antibody to IL-5 in cynomolgus monkeys. In 2024, this provider wrote 14 Medicare prescriptions for Nucala, about 73% of the volume of the typical New Mexico prescriber of this medication (19.2). Medicare paid an average of $4,287.98 per fill, versus $4,493.77 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NM prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NM average for this medication. 14 30-Day Fills standardized to 30-day supplies 392 Days of Medication total across all patients in 2024 | |||
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 13 | $203.92▼ below NM avg | ▼ Less than typical |
About Budesonide-Formoterol Fumarate: This product is used to control and prevent symptoms (wheezing and shortness of breath) caused by asthma or ongoing lung disease (chronic obstructive pulmonary disease-COPD, which includes chronic bronchitis and emphysema). Show more ▾ It contains 2 medications: budesonide and formoterol. Budesonide belongs to a class of drugs known as corticosteroids. It works by reducing the irritation and swelling of the airways. Formoterol belongs to the class of drugs known as long-acting beta agonists. It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. Controlling symptoms of breathing problems can decrease time lost from work or school. When used alone, long-acting beta agonists (such as formoterol) may rarely increase the risk of serious (sometimes fatal) asthma-related breathing problems. However, combination inhaled corticosteroid and long-acting beta agonists, such as this product, do not increase the risk of serious asthma-related breathing problems. Before using this medication, it is important to learn how to use it properly. If an asthma attack occurs, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed. See also How to Use section. In 2024, this provider wrote 13 Medicare prescriptions for Budesonide-Formoterol Fumarate, about 63% of the volume of the typical New Mexico prescriber of this medication (20.5). Medicare paid an average of $203.92 per fill, versus $231.28 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NM prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NM average for this medication. 13 30-Day Fills standardized to 30-day supplies 390 Days of Medication total across all patients in 2024 | |||
| Tiotropium Bromide | 13 | $386.12▼ below NM avg | ≈ Typical |
About Tiotropium Bromide: Tiotropium is used to control and prevent symptoms (such as wheezing, shortness of breath) caused by ongoing lung disease (chronic obstructive pulmonary disease-COPD which includes bronchitis and emphysema). Show more ▾ It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. Tiotropium belongs to a class of drugs known as anticholinergics. Controlling symptoms of breathing problems can decrease time lost from work or school. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden breathing problems. If wheezing or sudden shortness of breath occurs, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed. A scopolamine derivative and CHOLINERGIC ANTAGONIST that functions as a BRONCHODILATOR AGENT. It is used in the treatment of CHRONIC OBSTRUCTIVE PULMONARY DISEASE. In 2024, this provider wrote 13 Medicare prescriptions for Tiotropium Bromide, about 90% of the volume of the typical New Mexico prescriber of this medication (14.5). Medicare paid an average of $386.12 per fill, versus $426.32 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NM prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NM average for this medication. 13 30-Day Fills standardized to 30-day supplies 390 Days of Medication total across all patients in 2024 | |||
| Doxycycline Hyclate | 13 | $7.41▼ below NM avg | ▼ Less than typical |
About Doxycycline Hyclate: This medication is used to treat a wide variety of bacterial infections, including those that cause acne. Show more ▾ This medication is also used to prevent malaria. This medication is known as a tetracycline antibiotic. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. A synthetic tetracycline derivative with similar antimicrobial activity. In 2024, this provider wrote 13 Medicare prescriptions for Doxycycline Hyclate, about half the volume of the typical New Mexico prescriber of this medication (26.4). Medicare paid an average of $7.41 per fill, versus $13.67 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NM prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NM average for this medication. 13 30-Day Fills standardized to 30-day supplies 103 Days of Medication total across all patients in 2024 | |||
| BreynaBudesonide/Formoterol Fumarate | 13 | $243.88 | ▼ Less than typical |
About Breyna: This product is used to control and prevent symptoms (wheezing and shortness of breath) caused by asthma or ongoing lung disease (chronic obstructive pulmonary disease-COPD, which includes chronic bronchitis and emphysema). Show more ▾ It contains 2 medications: budesonide and formoterol. Budesonide belongs to a class of drugs known as corticosteroids. It works by reducing the irritation and swelling of the airways. Formoterol belongs to the class of drugs known as long-acting beta agonists. It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. Controlling symptoms of breathing problems can decrease time lost from work or school. When used alone, long-acting beta agonists (such as formoterol) may rarely increase the risk of serious (sometimes fatal) asthma-related breathing problems. However, combination inhaled corticosteroid and long-acting beta agonists, such as this product, do not increase the risk of serious asthma-related breathing problems. Before using this medication, it is important to learn how to use it properly. If an asthma attack occurs, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed. See also How to Use section. In 2024, this provider wrote 13 Medicare prescriptions for Breyna, about half the volume of the typical New Mexico prescriber of this medication (22.2). Medicare paid an average of $243.88 per fill, versus $221.15 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NM prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 21 30-Day Fills standardized to 30-day supplies 630 Days of Medication total across all patients in 2024 | |||
| Atrovent HfaIpratropium Bromide | 13 | $606.24 | ≈ Typical |
About Atrovent Hfa: Ipratropium is used to control and prevent symptoms (wheezing and shortness of breath) caused by ongoing lung disease (chronic obstructive pulmonary disease-COPD which includes bronchitis and emphysema). Show more ▾ It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. Controlling symptoms of breathing problems can decrease time lost from work or school. For preventing symptoms of lung disease, this medication must be used regularly to be effective. Use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) for wheezing or sudden shortness of breath unless otherwise directed by your doctor. Ipratropium does not work as fast as your quick-relief inhaler, but may sometimes be used to relieve symptoms of wheezing or sudden shortness of breath if so prescribed by your doctor. A muscarinic antagonist structurally related to ATROPINE but often considered safer and more effective for inhalation use. It is used for various bronchial disorders, in rhinitis, and as an antiarrhythmic. In 2024, this provider wrote 13 Medicare prescriptions for Atrovent Hfa, about 79% of the volume of the typical New Mexico prescriber of this medication (16.4). Medicare paid an average of $606.24 per fill, versus $555.42 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NM prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 15.7 30-Day Fills standardized to 30-day supplies 436 Days of Medication total across all patients in 2024 | |||
| Pirfenidone | 12 | $6,423.48 | ▼ Less than typical |
About Pirfenidone: Pirfenidone is used to treat a certain lung disease called idiopathic pulmonary fibrosis (IPF). Show more ▾ This disease causes the lungs to get scarred and become stiff, making it hard to breathe. Pirfenidone may help slow down the worsening of your IPF. In 2024, this provider wrote 12 Medicare prescriptions for Pirfenidone, about 71% of the volume of the typical New Mexico prescriber of this medication (17). Medicare paid an average of $6,423.48 per fill, versus $3,887.27 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NM prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 12 30-Day Fills standardized to 30-day supplies 360 Days of Medication total across all patients in 2024 | |||
| Budesonide | 12 | $414.85 | ▼ Less than typical |
About Budesonide: Budesonide is used to control and prevent symptoms (wheezing and shortness of breath) caused by asthma. Show more ▾ This medication belongs to a class of drugs known as corticosteroids. It works directly in the lungs to make breathing easier by reducing the irritation and swelling of the airways. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden asthma attacks. If an asthma attack occurs, use your quick-relief inhaler as prescribed. A glucocorticoid used in the management of ASTHMA, the treatment of various skin disorders, and allergic RHINITIS. In 2024, this provider wrote 12 Medicare prescriptions for Budesonide, about 68% of the volume of the typical New Mexico prescriber of this medication (17.7). Medicare paid an average of $414.85 per fill, versus $182.66 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NM prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 12 30-Day Fills standardized to 30-day supplies 360 Days of Medication total across all patients in 2024 | |||
| Losartan Potassium | 11 | $14.88 | ▼ Less than typical |
About Losartan Potassium: Losartan is used to treat high blood pressure (hypertension) and to help protect the kidneys from damage due to diabetes. Show more ▾ It is also used to lower the risk of strokes in patients with high blood pressure and an enlarged heart. Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. Losartan belongs to a class of drugs called angiotensin receptor blockers (ARBs). It works by relaxing blood vessels so that blood can flow more easily. An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II. In 2024, this provider wrote 11 Medicare prescriptions for Losartan Potassium, about 11% of the volume of the typical New Mexico prescriber of this medication (97.2). Medicare paid an average of $14.88 per fill, versus $11.57 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NM prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 33 30-Day Fills standardized to 30-day supplies 990 Days of Medication total across all patients in 2024 | |||
| OfevNintedanib Esylate | 11 | $14,918.67 | ▼ Less than typical |
About Ofev: This medication is used to treat certain types of lung disease (idiopathic pulmonary fibrosis- IPF, interstitial lung disease). Show more ▾ Both types of lung disease scar and stiffen your lungs, making it hard to breathe. Nintedanib may help slow down the worsening of your lung disease. In 2024, this provider wrote 11 Medicare prescriptions for Ofev, about a third of the volume of the typical New Mexico prescriber of this medication (34.8). Medicare paid an average of $14,918.67 per fill, versus $13,205.09 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NM prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 11 30-Day Fills standardized to 30-day supplies 330 Days of Medication total across all patients in 2024 | |||
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 11 | $14.60 | ▼ Less than typical |
About Amoxicillin-Clavulanate Potass: Amoxicillin/clavulanic acid is a combination penicillin-type antibiotic used to treat a wide variety of bacterial infections. Show more ▾ It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. In 2024, this provider wrote 11 Medicare prescriptions for Amoxicillin-Clavulanate Potass, about half the volume of the typical New Mexico prescriber of this medication (25.8). Medicare paid an average of $14.60 per fill, versus $10.63 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NM prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 11 30-Day Fills standardized to 30-day supplies 98 Days of Medication total across all patients in 2024 | |||
| Ipratropium Bromide | 11 | $18.41▼ below NM avg | ▼ Less than typical |
About Ipratropium Bromide: Ipratropium is used to treat a runny nose caused by the common cold or seasonal allergies. Show more ▾ It works by reducing the amount of fluid/mucus released from inside your nose. This medication does not relieve symptoms of stuffy nose or sneezing. A muscarinic antagonist structurally related to ATROPINE but often considered safer and more effective for inhalation use. It is used for various bronchial disorders, in rhinitis, and as an antiarrhythmic. In 2024, this provider wrote 11 Medicare prescriptions for Ipratropium Bromide, about a third of the volume of the typical New Mexico prescriber of this medication (34.5). Medicare paid an average of $18.41 per fill, versus $31.74 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NM prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NM average for this medication. 15 30-Day Fills standardized to 30-day supplies 406 Days of Medication total across all patients in 2024 | |||
About this data. The prescription history for DR. CHIDOZIE CHARLES AGU M.D. is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Internal Medicine prescribing approach at this Albuquerque, NM practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among NM prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.
About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.
